HomeMARKSANS • NSE
add
Marksans Pharma Ltd
Previous close
₹187.54
Day range
₹183.58 - ₹188.80
Year range
₹156.00 - ₹270.70
Market cap
84.74B INR
Avg Volume
798.90K
P/E ratio
23.50
Dividend yield
0.43%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 7.54B | 10.64% |
Operating expense | 3.02B | 13.70% |
Net income | 1.13B | 8.26% |
Net profit margin | 15.01 | -2.15% |
Earnings per share | 2.50 | — |
EBITDA | 1.50B | 15.33% |
Effective tax rate | 24.52% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.67B | -0.70% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 27.14B | — |
Shares outstanding | 452.81M | — |
Price to book | 3.16 | — |
Return on assets | — | — |
Return on capital | 11.20% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.13B | 8.26% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1992
Website
Employees
1,840
